WHAT'S NEW
- Topics, Trends & Updates for March (3/14/24)
- Updated: Management of IRIS (3/7/24)
- Topics, Trends & Updates for February (2/8/24)
- Updated: Treatment of Opioid Use Disorder (2/2/24)
- Topics, Trends & Updates for December (12/1/23)
- New: Doxycycline-PEP to Prevent Bacterial STIs (9/25/23)
- Topics, Trends & Updates for October (10/12/23)
- New: Q/A: NYS Medical Management of Perinatal HIV Exposure (10/11/23)
- Updated: Treatment of Alcohol Use Disorder (10/2/2023)
- Updated: Substance Use Harm Reduction in Medical Care (9/25/23)
- Topics, Trends & Updates for September (9/14/23)
- Updated: Treatment of Opioid Use Disorder (9/12/23)
- New: Clinical Guidelines Program Approach to Shared Decision-Making (8/8/23)
- Topics, Trends & Updates for July (7/13/23)
- New Clinical Guidance: Stimulant Use (7/3/23)
- Updated: NYS Good Practices to Prevent Perinatal HIV Transmission (6/26/23)
- Updated: Diagnosis and Management of HIV-2 in Adults (6/20/23)
- Updated: HIV Resistance Assays (6/20/23)
- Updated: COVID-19 Immunization Recommendations (6/8/23)
- Updated: Use of Injectable CAB/RPV LA as Replacement ART in Virally Suppressed Adults (5/15/23)
- Topics, Trends & Updates for May (5/11/23)
- Updated: Second-Line ART After Treatment Failure or for Regimen Simplification (5/10/23)
- Updated: Immunizations recommendations -- MenB (5/9/23)
- Updated: Guidance: Addressing the Needs of Older Patients in HIV Care (5/5/23)
- Updated: ART Drug-Drug Interactions with lenacapavir (LEN) (4/26/23)
MPOX & COVID-19 UPDATES
- NYCDOHMH: Additional Dose of COVID-19 Vaccine for People 65 Years of Age and Older (3/1/24)
- NYSDOH Health Alert Notice: Mpox Cases Associated with Person-to-Person Transmission (11/27/23)
- FDA Clears First COVID-19 Home Antigen Test (11/9/23)
- FDA Authorizes Updated Novavax COVID-19 Vaccine Formulated to Better Protect Against Currently Circulating Variants (10/3/23)
- CDC Update: Updated COVID-19 Vaccines are Recommended for Everyone Aged 6 Months and Older (9/13/23)
- FDA Takes Action on Updated mRNA COVID-19 Vaccines to Better Protect Against Currently Circulating Variants (9/11/23)
- NYCDOHMH: Providing COVID-19 Vaccines Following Commercialization (9/8/23)
- FDA Permits Marketing of First COVID-19 At-Home Test Using Traditional Premarket Review Process (6/6/23)
- FDA Approves First Oral Antiviral for Treatment of COVID-19 in Adults (5/25/23)
- NYSDOH AI Dear Colleague Letter: New York State’s continued response to mpox (5/19/23)
- NYSDOH AI Health Advisory: Mpox Cases Associated with Person-to-Person Transmission (5/2/23)
- NYSDOH & NYCDOHMH Launch Mpox Vaccine Campaigns Urging Eligible New Yorkers to Prepare Now for a Healthy Summer (5/2/23)
- NYCDOHMH Dear Colleague: COVID-19 Vaccination Updates (4/21/23)
- FDA Authorizes Changes to Simplify Use of Bivalent mRNA COVID-19 Vaccines (4/18/23)
- NYSDOH AI & NYCDOHMH Mpox Dear Colleague Letter Announcing Spring and Summer Media Campaign (3/27/23)
- FDA Authorizes Bivalent Pfizer-BioNTech COVID-19 Vaccine as Booster Dose for Certain Children 6 Months through 4 Years of Age (3/14/23)
- FDA Authorizes First Over-the-Counter At-Home Test to Detect Both Influenza and COVID-19 Viruses (2/27/23)
- NYCDOHMH: Bivalent COVID-19 Vaccines for Children Ages 6 Months Through 5 Years (12/14/22)
- FDA Authorizes Updated (Bivalent) COVID-19 Vaccines for Children Down to 6 Months of Age (12/8/22)
- NYSDOH Statement on Mpox Name Change (12/1/22)
- WHO Recommends New Name for Monkeypox Disease (11/30/22)
- NYCDOHMH: Novavax COVID-19 Boosters Allowed for People Ages 18 Years and Older (11/1/22)
- NYCDOHMH: Considerations for Monkeypox and Pregnant, Recently Pregnant, and Breastfeeding Patients (10/19/22)
- NYCDOHMH: Bivalent COVID-19 Booster Recommendation Expanded to Include Children Ages 5 to 11 Years (10/15/22)
- New NYS Regulation: Minor Consent Allowed for Monkeypox Services (10/14/22)
HOT TOPICS
- CEI Newsletter (3/26/24)
- CEI: Intensive Clinical Preceptorship Program: Hepatitis C Treatment and Comprehensive Care for People Who Use Drugs (3/26/24)
- NYS Medicaid Update – February 2024 (3/18/24)
- AETC NCRC Quarterly Newsletter - Spring 2024 (3/13/24)
- NYSDOH Dear Colleague Letter: Updated Hepatitis C Screening Requirements for All Adults (3/4/24)
- NYSDOH Dear Colleague Letter: Updated Hepatitis C Screening Requirements for Pregnant People (3/4/24)
- HIVinfo: Recommendations for Statins in People with HIV (2/27/24)
- NYSDOH Dear Colleague Letter: Updated Medical Provider HIV/AIDS and Partner/Contact Report Form (2/27/24)
- New CEI clinical cards for Buprenorphine/Naloxone available now (2/27/24)
- HIVinfo: Updates to the Perinatal HIV Clinical Guidelines (1/31/24)
- NYSDOH AI: Call for Presentations for the 2024 NYS Annual Hepatitis C Elimination Progress Report Meeting (12/14/23)
- HIVinfo: Updates to the Adult and Adolescent Antiretroviral Guidelines (12/6/23)
- NYCDOH&MH: Free CME on Care for Men Who Have Sex With Men Still Available (11/30/23)
- NYS Bureau of HIV/AIDS Epidemiology: 2023 Changes to Provider Reporting of HIV in New York State (11/27/23)
- NYSDOH Dear Colleague Letter: Changes to NYS Public Health Law Regarding Provider Reporting of HIV (11/27/23)
- HIVMA & IDSA Foundation: HIV Clinical Fellowship Program – Call for Applications Open (11/16/23)
- FDA Grants Marketing Authorization of First Test for Chlamydia and Gonorrhea with at-home Sample Collection (11/15/23)
- Governor Hochul Signs Legislation to Develop an Outreach Program About the Impact of Medical Treatments on Intersex Individuals (11/13/23)
- NYSDOH AI: HIV Self Test Giveaway starts November 13th (11/13/23)
- NYSDOH AI: Registration is Open for the ETE Summit and World AIDS Day (11/2/23)
- NYSDOH AI: PrEP Aware Week Returns (10/23/23)
- New from NASTAD: PrEP, PEP, and Other HIV Prevention Strategies: Billing and Coding Guide (10/10/23)
- NYSDOH AI: PrEP Aware Week 2023 Website and Toolkit (10/4/23)
- UW: National HIV Curriculum 3rd Edition Now Available (9/26/23)
- HIVinfo: Updates to the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV (9/25/23)
CEI TRAINING & EVENTS
- 04/10/2024: Sexual Health ECHO: Chlamydial and Gonococcal Infections in Infants
- 04/17/2024: HCV and Drug User Health COE: Hepatitis B and C: Coinfection and Reactivation
- 04/17/2024: HCV and Drug User Health COE: Trauma Informed Care for People Who Use Drugs
- 04/17/2024: HIV Primary Care and Prevention This Month in HIV: Medical Marijuana: Exploring New Clinical Options in NYS
- 05/07/2024: HCV and Drug User Health: Stimulant Use Disorder: Clinical Practice Guidelines for The Primary Care Provider (Part 2)
- 05/10/2024: Sexual Health COE: 10th Annual NYS Sexual Health Conference
GENERAL TRAINING & EVENTS
- 04/03/2024: Minority AIDS Initiative: Chronic Mental Health Issues & Substance Use Disorders in HIV Care
- 04/05/2024: NAHEWD: Syndemic Solutions: Community Based Syndemic Approaches in Action
- 04/05/2024: The AIDS Institute: 10th Annual Rural HIV Research & Training Conference
- 04/05/2024: Northeast/Caribbean AETC: CROI 2024 Update
- 04/16/2024: Pacific AETC: Activating Patient, Community & Structural Refusal, Resistance, and Resilience: Multi-Level Approaches in Transforming HIV Care for Black Women and People
- 04/17/2024: Northeast/Caribbean AETC: HIV Vaccines Update and REPRIEVE Trial Results
- 04/18/2024: MidAtlantic AETC: Building Access to HIV Prevention & Treatment: Current Issues & Approaches
- 04/23/2024: NYSDOH AI: Ending Preventable Epidemics: Updates on New York State Hepatitis C and Syphilis Screening Requirements
- 05/02/2024: South Central AETC: 2024 National Latinx Conference on HIV/HCV/SUD
- 05/02/2024: ACTHIV 2024, the 18th Annual American Conference for the Treatment of HIV
- 05/02/2024: BNGAP: LGBT Health Workforce Conference
- 05/02/2024: Northeast/Caribbean AETC: Ending the HIV Epidemic: What’s Research Got To Do With It?
- 05/03/2024: NAHEWD: Xylazine: What the HIV Care Team Needs to Know
- 05/07/2024: AHA: Accelerating Health Equity Conference
- 05/07/2024: Minority AIDS Initiative: PrEP Uptake in Black Women: A Larger Scope
- 05/15/2024: MidAtlantic AETC: HIV and Mental Health
- 05/23/2024: MidAtlantic AETC: Special Considerations for Addressing Gender Dysphoria in Persons with HIV
- 06/04/2024: Minority AIDS Initiative: Sexual Health, HIV, and Disabilities
- 07/22/2024: AIDS 2024, the 25th International AIDS Conference
- 09/16/2024: 2024 STI Prevention Conference